Skip to content

Founder

Ozue Ezeife

Founder, AlphaCitation


Ozue Ezeife, Founder of AlphaCitation
Ozue Ezeife

Ozue created AlphaCitation after more than a decade working at the intersection of market access, pricing, evidence and commercial strategy in healthcare.

He spent more than a decade in pharmaceutical market access, most recently as Regional Pricing & Access Director for Asia-Pacific at Novo Nordisk, after roles across Africa and the Middle East. His work spanned payer engagement, pricing, reimbursement, tenders and market development in metabolic, endocrine and rare-disease portfolios, across highly varied healthcare systems.

That experience shaped the thinking behind AlphaCitation: as AI increasingly influences how products and categories are understood, brand teams need a rigorous way to see what AI is saying, trace why it is saying it, verify the evidence behind it, and act on the commercial implications.

AlphaCitation is building the intelligence, evidence and accountability infrastructure for how AI represents medicines, clinical evidence and treatment decisions.